MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
Pharmaceutical Executive
May 1, 2007
Sarah Houlton
Global Report: Pure and Simple The european union is set to overhaul the way it monitors drug safety to help make sense of a decentralized system that has been criticized for being ineffective. Will the EC's upcoming drug-safety plan be just what the doctor ordered or end up an indecent proposal? mark for My Articles similar articles
Pharmaceutical Executive
June 1, 2011
A Lack of Information Why has the EU still not managed to update its rules on information about medicines? mark for My Articles similar articles
Pharmaceutical Executive
July 1, 2005
Sarah Houlton
Global Report: Still Waiting Pharma industry and traders both want a decision on parallel trade in Europe--but not the same one. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2005
Sarah Houlton
Global Report: Kids 'R' EU After years of delay, the European Parliament is ready to vote on pediatric-testing legislation. mark for My Articles similar articles
Pharmaceutical Executive
November 1, 2011
Europe Tackles 'Advertising in Disguise' Fears The EC's latest proposals have thrown water on Europe's fiery Direct-to-Consumer advertising debate. But is it enough to keep the flames at bay? mark for My Articles similar articles
Pharmaceutical Executive
November 1, 2006
Sarah Houlton
Global Report: 'Bout Time The European Union has been late to enter the fight against counterfeiting. Fed up, Parliament has passed a proposal designed to give its countries the nudge they need. mark for My Articles similar articles
Pharmaceutical Executive
November 1, 2013
Timothy Denman
Supply Chain: Scanning the Future The US and Europe are moving toward the enactment of new legislation that will change the way pharma products are handled and shipped throughout the supply chain. mark for My Articles similar articles
Chemistry World
April 24, 2014
Emma Stoye
European parliament backs new rules on legal highs New regulations that will make it easier to ban legal highs have been backed by the European parliament. mark for My Articles similar articles
Chemistry World
August 17, 2015
Anthony King
Greek crisis puts pressure on pharmaceuticals Supplies of critical drugs to Greek pharmacies have become sparse and erratic as the economic crisis squeezes public spending mark for My Articles similar articles
Pharmaceutical Executive
April 1, 2014
Whatever Happened To Faster Reimbursement For Generics In Europe? The plan to accelerate generic pricing and reimbursement has become another tragic European casualty. mark for My Articles similar articles
Pharmaceutical Executive
July 1, 2014
Europe Gears Up to Attack Counterfeit Medicines -- But Only Some of Them Cross-sector partnership seeks support for a pan-European system to keep fake drugs out, but obstacles are many. mark for My Articles similar articles
Pharmaceutical Executive
April 1, 2011
Dalli's Formula Fails the Efficacy Test EU leadership on pharma policy leaves many wondering of the right man is at the helm. mark for My Articles similar articles
Chemistry World
July 10, 2012
Interview: EMA head Guido Rasi His five-year appointment comes during a period of dramatic change for the pharma industry, which is struggling with patent expirations for many of its biggest selling drugs and a paucity of new drugs coming through the pipeline to take their place. mark for My Articles similar articles
Chemistry World
September 30, 2014
Transparency measures forced on pharma Previous misdemeanors are compelling the pharmaceutical industry to be more open with financial information and clinical data. mark for My Articles similar articles
Pharmaceutical Executive
April 10, 2014
Obama Policies Reshape Pharma Marketing Health reform initiatives promote transparency, challenge reimbursement, writes Jill Wechsler. mark for My Articles similar articles
Chemistry World
November 3, 2015
Ned Stafford
GM food and feed law falters in EU parliament Both GMO supporters and opponents applauded parliament's rejection of the proposed law. mark for My Articles similar articles
Pharmaceutical Executive
May 1, 2011
Seeing Through the Transparency Directive The EU is largely powerless when it comes to policies over pharma pricing and reimbursement. mark for My Articles similar articles
Pharmaceutical Executive
April 1, 2011
Revisiting Reform Courts, Congress review policies and programs shaping drug costs and access. mark for My Articles similar articles
Chemistry World
November 18, 2010
Ned Stafford
New drug pricing rules in Germany The law was approved on 11 November and will take effect from 1 January as part of an effort to rein in exploding costs for Germany's massive public health insurance system. mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2011
Jill Wechsler
Politics & PDUFA Pharma companies will assess health reform, negotiate user fees and keep an eye on federal prosecutors in the year ahead. mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2011
Sweden: Setting the Pace for Global Pharma On health system decentralization, regulatory convergence, drug detailing, promotion, patient information, the environment, value-based pricing, and the pursuit of cost-effectiveness, the Nordics have been true innovators over the past decades. mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2006
Sarah Houlton
Global Report: Please Come Back Health authorities in Europe are working hard to reestablish their countries as preferred locations for pharma's R&D facilities. Fortunately, they've got a blueprint: China. mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2012
Peter O'Donnell
Richard Bergstrom -- Europe's Medicine Man The new head of the European Federation of Pharmaceutical Industries and Associations faces a Promethean challenge: selling the merits of costly science and innovation in an era of bristling competition, fiscal crisis, and declining demographics. mark for My Articles similar articles
Pharmaceutical Executive
December 1, 2008
Jill Wechsler
Challenge and Challenges Expanded healthcare coverage also fits the goals of pharma manufacturers. mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2007
Sarah Houlton
Global Report: No Satisfaction Germans on both sides of the political spectrum agree that their country's healthcare system needs reform. The latest attempt at change, though, doesn't really meet either side's needs. mark for My Articles similar articles
Chemistry World
April 27, 2015
Ned Stafford
European parliament refuses to back diversion of research cash Key European parliament committees have overwhelmingly rejected a proposal to divert euro 2.7 billion of research funding to help finance a new EU-wide economic stimulus package. mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2012
Jill Wechsler
New Year, New Issues Look for action in 2012 on drug access, shortages, innovation, and transparency. The 800-pound gorilla in the room is the looming Supreme Court decision on the constitutionality of the Obama health reform legislation. mark for My Articles similar articles
Pharmaceutical Executive
January 21, 2014
Comer & Upton
Pharm Exec's Annual Industry Outlook 2014 For Big Pharma, the merits of strategic focus and operational discipline are more important than ever. It is time to be decisive; muddling through is so yesterday. mark for My Articles similar articles
Pharmaceutical Executive
May 1, 2007
Peter Pitts
Opinion: Are Price Controls the New Black? A revamped version of an old bill calling for drug importation is on the congressional runway. With bipartisan backing and red-hot Rahmed-up rhetoric, the legislation might just pass -- and spell failure for the future of innovative drug development. mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2006
Sarah Houlton
Global Report: The UK's New Code of Conduct Pharma companies' relationships with doctors are being tightened in the United Kingdom, after a major overhaul of the Association of the British Pharmaceutical Industry's Code of Practice. mark for My Articles similar articles
The Motley Fool
February 8, 2011
Brian Orelli
A Few Extra Years of Sales? Yes, Please! An EU-Canadian proposal could help drugmakers. mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2011
The Steep, Slow Climb A survey of leading experts reveals 2011's sobering reality and the trends that smart drugmakers will follow into the next decade. mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2014
Eruptions on the Drug-Pricing Horizon in Europe An escalating political debate over pharma pricing and reimbursement nears the boiling point. mark for My Articles similar articles
Pharmaceutical Executive
March 1, 2012
Jill Wechsler
When Talk is Not So Cheap FDA and industry are pushing user fees, while they struggle with curbs on communications. mark for My Articles similar articles
Pharmaceutical Executive
December 1, 2010
The Sum of All His Parts: Career Reflections of Europe's Chief Drug Regulator The European Medicines Agency is a unique institution, pursuing a mandate shared with a complex web of national and regional groups, each able to place a distinctive imprint around the delicate task of certifying the safety and efficacy of new drugs. mark for My Articles similar articles
Pharmaceutical Executive
June 1, 2014
Hopes High as EU Heads Into Leadership Change The principal drug industry associations in Europe launched a call in mid-May for "an integrated European industrial policy for the pharmaceuticals sector." mark for My Articles similar articles
Pharmaceutical Executive
May 1, 2011
Julian Upton
UK Stakeholders Have Their Say on Value-Based Pricing The UK coalition government's consultation on the intro of value-based pricing has invited caution and resistance. mark for My Articles similar articles
Pharmaceutical Executive
January 1, 2007
Glass & Poli
Forecast 2007: Connecting the Dots How do execs rank the issues facing the pharmaceutical industry? And what are the links they see between them? A new study reveals the industry's mental map of today's challenges. mark for My Articles similar articles
The Motley Fool
July 30, 2010
Brian Orelli
A Faster Pathway to Drug Approvals A thinktank called the Pacific Research Institute has proposed letting drugs approved by the European Medicines Authority onto the market in the U.S. before the Food and Drug Administration has approved the drugs. mark for My Articles similar articles
The Motley Fool
January 7, 2005
Brian Gorman
Canadian Drug Sales Might End Drug makers may not have to worry about cheap pills flooding into the U.S. from across the border, at least for now, offering a small consolation to investors. mark for My Articles similar articles
Chemistry World
February 18, 2014
Ned Stafford
GM maize poised for approval in Europe The European commission is on the verge of authorizing a genetically modified maize for cultivation after ministers from EU member nations last week failed to muster a large enough majority to reject the crop. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2014
Peril, Not Progress on Transatlantic Trade Deal Pharma hopes for a deal are fading as the once-hot TTIP talks seem to be on the fizzle in Europe. mark for My Articles similar articles
Chemistry World
June 19, 2014
Ned Stafford
EU plan to let member states decide on GM The European council of environment ministers would allow member states to go it alone and ban the cultivation of genetically modified crops. mark for My Articles similar articles
Pharmaceutical Executive
February 1, 2011
Jon Zifferblat
China: Business as UNusual If there is one market that requires a click on the 'refresh' button, it's China. General Biologic provides a snapshot of what's ahead for Big Pharma in the country mark for My Articles similar articles
Chemistry World
July 25, 2012
Pharma Industry May Suffer as India Looks to Generics India plans to provide free generic drugs to half its population. mark for My Articles similar articles
Pharmaceutical Executive
December 1, 2012
Jill Wechsler
Obamacare, Innovation and Pricing Tax and budget decisions will shape the healthcare market and drug research and regulation. mark for My Articles similar articles
Pharmaceutical Executive
February 1, 2014
Will Europe's Regulatory Watchdog Come Of Age In 2014? The author looks at the growing pains of the European Medicine Agency as it faces key policy challenges of 2014. mark for My Articles similar articles
Pharmaceutical Executive
November 1, 2013
Jill Wechsler
Transparency Troubles for Pharma High prices, murky financial relations, and a reluctance to disclose clinical data undermine public trust in industry and the research enterprise. mark for My Articles similar articles
The Motley Fool
January 28, 2005
Karl Thiel
Will the FDA Kill Biotech? Proposed legislation could spell changes across the pharmaceutical world. Investors are right to be nervous. mark for My Articles similar articles
Chemistry World
January 6, 2014
Sarah Houlton
Weathering the storm Pharma is in the middle of a strategic crisis, if a report published at the start of 2013 by Roland Berger Strategy Consultants is to be believed. mark for My Articles similar articles